Similar articles

• DTPA-coupled antibodies labeled with yttrium-90.

  Hnatowich DJ, Virzi F, Doherty PW. Hnatowich DJ, et al. J Nucl Med. 1985 May;26(5):503-9. J Nucl Med. 1985. PMID: 3989606
• Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.

  Kobayashi H, Wu C, Kim MK, Paik CH, Carrasquillo JA, Brechbiel MW. Kobayashi H, et al. Bioconjug Chem. 1999 Jan-Feb;10(1):103-11. doi: 10.1021/bc980091d. Bioconjug Chem. 1999. PMID: 9893971
• Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.

  Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC. Brouwers AH, et al. J Nucl Med. 2004 Feb;45(2):327-37. J Nucl Med. 2004. PMID: 14960657
• Pretargeted radioimmunotherapy.

  Meredith RF, Buchsbaum DJ. Meredith RF, et al. Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S57-9. doi: 10.1016/j.ijrobp.2006.04.058. Int J Radiat Oncol Biol Phys. 2006. PMID: 16979441 Review.
• Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody.

  Wiseman GA, White CA, Witzig TE, Gordon LI, Emmanouilides C, Raubitschek A, Janakiraman N, Gutheil J, Schilder RJ, Spies S, Silverman DH, Grillo-López AJ. Wiseman GA, et al. Clin Cancer Res. 1999 Oct;5(10 Suppl):3281s-3286s. Clin Cancer Res. 1999. PMID: 10541376 Review.